Novel Approaches of Anticancer Therapy

Dear Colleagues,

Many proteins or micro-RNAs involved in the development of cancers, proliferation, and apoptosis of cancer cells have been discovered, and many molecules have been developed against these targets to fight cancer. Despite these advances, too many patients still die of cancer due to late detection, low treatment efficacy, or resistance to treatment leading to tumor restart and/or metastasis. It is therefore necessary and urgent to pursue our efforts to find new targets and new molecules to improve the efficacy of cancer treatments and patient survival. This Special Issue will highlight present efforts in medicinal chemistry and pharmacology with studies of new molecules directed against known targets or against targets recently identified as being involved in the development and progression of cancer, and new molecules inhibitors of the resistance of cancer cells to current therapies, which is the main factor of treatment failure. This Special Issue welcomes original and review articles on recent advances and emerging concepts in the latest strategies in the fight against cancer.

You may choose our Joint Special Issue in Molecules.

Dr. Isabelle Mus-Veteau
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Chemistry is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• anticancer/antitumor treatment
• novel anticancer molecules
• inhibitors of chemotherapy resistance
• chemotherapy
• targeted therapy
• medicinal chemistry
• pharmacology

• Novel Approache of Anticancer Therapy in Molecules (12 articles)